ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/12/12 | 3,645 | 3,855 | 3,620 | 3,770 | -135 | -3.5% | 325,100 |
| 2018/12/11 | 3,940 | 3,995 | 3,855 | 3,905 | +20 | +0.5% | 148,900 |
| 2018/12/10 | 4,015 | 4,060 | 3,845 | 3,885 | -245 | -5.9% | 221,300 |
| 2018/12/07 | 4,140 | 4,190 | 4,040 | 4,130 | +80 | +2% | 193,000 |
| 2018/12/06 | 4,250 | 4,265 | 3,980 | 4,050 | -235 | -5.5% | 323,700 |
| 2018/12/05 | 4,145 | 4,340 | 4,130 | 4,285 | ±0 | ±0% | 201,800 |
| 2018/12/04 | 4,420 | 4,505 | 4,255 | 4,285 | -140 | -3.2% | 317,300 |
| 2018/12/03 | 4,365 | 4,425 | 4,265 | 4,425 | +200 | +4.7% | 267,000 |
| 2018/11/30 | 4,295 | 4,405 | 4,165 | 4,225 | -75 | -1.7% | 276,800 |
| 2018/11/29 | 4,335 | 4,375 | 4,255 | 4,300 | +50 | +1.2% | 251,900 |
| 2018/11/28 | 4,150 | 4,285 | 4,110 | 4,250 | +140 | +3.4% | 258,200 |
| 2018/11/27 | 4,075 | 4,190 | 4,025 | 4,110 | +80 | +2% | 248,600 |
| 2018/11/26 | 3,915 | 4,085 | 3,905 | 4,030 | +115 | +2.9% | 214,400 |
| 2018/11/22 | 3,870 | 3,955 | 3,820 | 3,915 | +45 | +1.2% | 176,400 |
| 2018/11/21 | 3,905 | 4,025 | 3,840 | 3,870 | -125 | -3.1% | 285,400 |
| 2018/11/20 | 3,960 | 4,050 | 3,875 | 3,995 | +25 | +0.6% | 339,700 |
| 2018/11/19 | 3,725 | 3,980 | 3,665 | 3,970 | +300 | +8.2% | 339,500 |
| 2018/11/16 | 3,670 | 3,780 | 3,660 | 3,670 | +35 | +1% | 207,200 |
| 2018/11/15 | 3,460 | 3,695 | 3,445 | 3,635 | +110 | +3.1% | 272,100 |
| 2018/11/14 | 3,700 | 3,825 | 3,475 | 3,525 | -40 | -1.1% | 380,900 |
| 2018/11/13 | 3,435 | 3,620 | 3,405 | 3,565 | -10 | -0.3% | 197,900 |
| 2018/11/12 | 3,665 | 3,755 | 3,545 | 3,575 | -125 | -3.4% | 209,200 |
| 2018/11/09 | 3,555 | 3,755 | 3,550 | 3,700 | +140 | +3.9% | 246,000 |
| 2018/11/08 | 3,570 | 3,630 | 3,520 | 3,560 | +95 | +2.7% | 167,100 |
| 2018/11/07 | 3,400 | 3,565 | 3,325 | 3,465 | +65 | +1.9% | 317,300 |
| 2018/11/06 | 3,460 | 3,490 | 3,330 | 3,400 | -30 | -0.9% | 159,600 |
| 2018/11/05 | 3,310 | 3,490 | 3,230 | 3,430 | +75 | +2.2% | 205,300 |
| 2018/11/02 | 3,290 | 3,375 | 3,265 | 3,355 | +155 | +4.8% | 189,100 |
| 2018/11/01 | 3,265 | 3,320 | 3,200 | 3,200 | -115 | -3.5% | 166,000 |
| 2018/10/31 | 3,185 | 3,335 | 3,145 | 3,315 | +195 | +6.3% | 177,000 |
| 2018/10/30 | 2,940 | 3,135 | 2,930 | 3,120 | +110 | +3.7% | 210,400 |
| 2018/10/29 | 3,025 | 3,150 | 2,975 | 3,010 | +22 | +0.7% | 223,600 |
| 2018/10/26 | 3,225 | 3,275 | 2,930 | 2,988 | -172 | -5.4% | 366,600 |
| 2018/10/25 | 3,455 | 3,485 | 3,135 | 3,160 | -540 | -14.6% | 507,000 |
| 2018/10/24 | 3,760 | 3,765 | 3,635 | 3,700 | +10 | +0.3% | 138,100 |
| 2018/10/23 | 3,700 | 3,845 | 3,660 | 3,690 | -25 | -0.7% | 171,500 |
| 2018/10/22 | 3,680 | 3,755 | 3,595 | 3,715 | -15 | -0.4% | 149,000 |
| 2018/10/19 | 3,715 | 3,775 | 3,680 | 3,730 | -75 | -2% | 141,600 |
| 2018/10/18 | 3,850 | 3,905 | 3,780 | 3,805 | -65 | -1.7% | 121,000 |
| 2018/10/17 | 3,895 | 3,930 | 3,835 | 3,870 | +75 | +2% | 109,100 |
| 2018/10/16 | 3,840 | 3,910 | 3,755 | 3,795 | -65 | -1.7% | 121,700 |
| 2018/10/15 | 3,885 | 3,940 | 3,840 | 3,860 | -70 | -1.8% | 117,700 |
| 2018/10/12 | 3,795 | 3,935 | 3,765 | 3,930 | +130 | +3.4% | 180,500 |
| 2018/10/11 | 3,770 | 3,910 | 3,745 | 3,800 | -320 | -7.8% | 354,500 |
| 2018/10/10 | 4,060 | 4,145 | 3,945 | 4,120 | +120 | +3% | 207,000 |
| 2018/10/09 | 4,140 | 4,225 | 3,990 | 4,000 | -245 | -5.8% | 296,400 |
| 2018/10/05 | 4,335 | 4,430 | 4,235 | 4,245 | -160 | -3.6% | 191,300 |
| 2018/10/04 | 4,500 | 4,540 | 4,385 | 4,405 | -95 | -2.1% | 124,000 |
| 2018/10/03 | 4,400 | 4,535 | 4,300 | 4,500 | +55 | +1.2% | 206,900 |
| 2018/10/02 | 4,675 | 4,715 | 4,410 | 4,445 | -170 | -3.7% | 288,600 |
1551～
1600
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 223,700円 | +21.7% | +999.9% | 0.00% | 9.32倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.39倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 311,000円 | +3.0% | +27.5% | 2.57% | 19.69倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 149,500円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 225,100円 | +0.4% | -8.4% | 2.35% | 28.90倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
